The Silent Reversal: How Gen X and Elder Millennials Are Facing Worse Mortality Than Their Parents at the Same Age

A groundbreaking 2026 study has uncovered a troubling shift in American health trends: people born between 1970 and 1985 (late Generation X and early or “elder” Millennials) are dying at higher rates than previous generations did at the same ages. This isn’t just about overdoses or the pandemic—it points to deeper, longer-term problems involving rising chronic diseases and societal pressures that have created a “turning point” in U.S. life expectancy gains.

The Study and Its Methods

Published on March 9–17, 2026, in the Proceedings of the National Academy of Sciences (PNAS), the paper titled “Insights into US life expectancy stagnation from birth cohort mortality dynamics” was led by Leah Abrams, an assistant professor of community health and social epidemiologist at Tufts University. Co-authors included researchers from the University of Texas Medical Branch (notably Neil K. Mehta) and European institutions (Alyson van Raalte and Mikko Myrskylä), with Octavio Bramajo contributing key analysis. The team examined U.S. death certificate data from 1979 to 2023, covering birth cohorts from the 1890s through the 1980s. They used sophisticated demographic tools, including Lexis diagrams, to visualize mortality changes across both birth cohorts (people born in the same years, aging together) and calendar periods. This approach separated generational experiences from year-specific events, revealing patterns that period-only analyses often miss.

Key Findings: A Clear Turning Point

For decades, each new generation in the U.S. enjoyed lower mortality rates than the one before it at the same ages—a hallmark of 20th-century public health progress. That pattern broke with the 1950–1959 birth cohort (mid-Baby Boomers), which the study identifies as the pivotal “transition” or “turning point” group. Earlier cohorts showed steady improvements; this group and those after experienced stagnation or outright deterioration. The most alarming signals appear in cohorts born 1970–1985 (and extending into the late 1980s in some analyses). At young and middle-adult ages (roughly 30–45 in the 2010s and early 2020s), these groups displayed:

• Higher all-cause mortality.
• Increased deaths from cardiovascular disease (CVD), with stagnating or reversing long-term declines.
• Elevated cancer mortality, particularly colon cancer (rising notably from cohorts born around 1955 onward, with sharper increases in later groups) as well as contributions from lung cancer and other sites.
• Higher rates of external causes, including drug overdoses, suicides, accidents, and homicides—often labeled “deaths of despair.”

These trends are especially concerning because cancers and cardiovascular conditions are typically rare in people in their 30s and 40s. The study notes “concerning deterioration” and “deteriorating patterns” for post-1970 cohorts, warning that the risks will likely compound as these generations enter their 50s, 60s, and beyond. The analysis also highlights a broad period-based worsening starting around 2010 that affected nearly all adult cohorts, interacting with the underlying cohort disadvantages.

What’s Driving These Trends?

The researchers point to a complex mix of social, biological, and generational forces rather than any single cause:

• Rising obesity, poor diet, and related conditions — Strongly linked to the uptick in colorectal cancer and cardiovascular issues among younger adults.
• Historical exposures — Such as smoking patterns that still influence lung cancer in these cohorts.
• Broader social and economic stressors — Including economic pressures, inequality, and lifestyle factors that contribute to external causes and chronic disease.
• Human-made limitations — The U.S. has diverged from other high-income countries despite medical advances, suggesting systemic issues in prevention, healthcare access, and public policy.

Abrams emphasized that the problem extends far beyond overdoses: “For years, many assumed that drug overdoses in midlife explained stalled U.S. life expectancy. But our findings show that the problem is much broader.”

Implications for the Future

U.S. life expectancy has remained essentially flat since the 2010s despite ongoing medical innovations and economic growth. This study suggests the stall results from layered cohort disadvantages (especially post-1950s) combined with recent period effects. If unaddressed, the 1970–1985 cohorts could face significantly higher morbidity and mortality in coming decades, further widening gaps with peer nations.The authors call for holistic approaches: tackling obesity and diet-related risks, improving prevention for colon cancer (e.g., earlier screening or dietary interventions), addressing mental health and substance use, and confronting the social determinants that shape generational health.

A Wake-Up Call

This research paints a sobering picture but also offers clarity. By focusing on birth cohorts, it reveals that the U.S. longevity crisis isn’t just a snapshot of recent years—it reflects accumulated disadvantages that began decades ago and are now manifesting in younger generations. Reversing these trends will require sustained, multi-level action in public health, policy, and society.As Abrams and colleagues conclude, understanding these multilayered forces is essential if the United States hopes to resume progress in life expectancy.

Citations

1. Abrams L, Bramajo O, van Raalte A, Myrskylä M, Mehta NK. Insights into US life expectancy stagnation from birth cohort mortality dynamics. Proc Natl Acad Sci U S A. 2026;123(11):e2519356123. doi:10.1073/pnas.2519356123. Available at: https://www.pnas.org/doi/10.1073/pnas.2519356123
2. Tufts Now. Why Aren’t Americans Living Longer? March 9, 2026. https://now.tufts.edu/2026/03/09/why-arent-americans-living-longer
3. ScienceAlert / Yahoo News coverage (March 2026) summarizing the PNAS findings and quotes from Abrams.
4. Additional reporting: News-Medical.net, MedicalXpress, UTMB News (March 9–16, 2026).